63071-14-7

Basic information

• Product Name: 2-Pyridinecarboxaldehyde, 4-(phenylmethoxy)-
• Synonyms: 4-(Benzyloxy)picolinaldehyde;4-(benzyloxy)pyridine-2-carbaldehyde;4-Phenylmethoxypyridine-2-carbaldehyde;2-Pyridinecarboxaldehyde, 4-(phenylmethoxy)-
• CAS NO: 63071-14-7
• Molecular Formula: C₁₃H₁₁NO₂
• Molecular Weight: 213.23
• Mol File: 63071-14-7.mol

Chemical Properties

• Melting Point: 89.5 °C
• Boiling Point: 125-128 °C(Press: 0.02 Torr)
• Appearance: /
• Density: 1.191±0.06 g/cm3(Predicted)
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• PKA: 4.43±0.10(Predicted)
• CAS DataBase Reference: 2-Pyridinecarboxaldehyde, 4-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyridinecarboxaldehyde, 4-(phenylmethoxy)-(63071-14-7)
• EPA Substance Registry System: 2-Pyridinecarboxaldehyde, 4-(phenylmethoxy)-(63071-14-7)

Safety Data

• Hazardous Substances Data: 63071-14-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
2-Pyridinecarboxaldehyde, 4-(phenylmethoxy)is used as an intermediate in the manufacturing of a wide range of chemicals and pharmaceuticals. Its unique aromatic properties make it a valuable component in the synthesis of various drug molecules, contributing to the development of new therapeutic agents.
Used in Organic Synthesis:
In the field of organic synthesis, 2-Pyridinecarboxaldehyde, 4-(phenylmethoxy)is employed as a key building block for the creation of complex organic molecules. Its versatility in forming different chemical structures allows it to be used in the synthesis of a variety of compounds, including those with potential applications in various industries.

Upstream product

• 63071-11-4 4-(benzyloxy)-2-(hydroxymethyl)pyridine 
• 5470-22-4 4-chloropicolinic acid 
• 100727-49-9 4-(benzyloxy)picolinic acid 
• 100382-00-1 4-benzyloxypyridine-2-carbonitrile 
• 2683-66-1 4-benzyloxypyridine-N-oxide 
• 1124-33-0 4-nitraminopyridine N-oxide 
• 100-51-6 benzyl alcohol 

Relevant articles and documents

Novel heterocyclic derivative capable of being used as SHP2 inhibitor

The invention relates to a novel heterocyclic derivative capable of being used as an SHP2 inhibitor, specifically relates to a compound shown by a formula I or pharmaceutically acceptable salts thereof, further relates to a use of the compound shown by the formula I or the pharmaceutically acceptable salts thereof and a pharmaceutical composition thereof in drug preparation, and particularly relates to a use in preparation of drugs for treatment, inhibition or prevention of diseases or discomforts mediated by SHP2 activity.

NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS

This invention relates to certain novel pyrazine derivatives (Formula I) as SHP2 inhibitors which is shown as formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, this invention is directed to fused heterocyclic group derivatives useful as inhibitors of SHP2, methods for producing such compounds and methods for treating a SHP2-mediated disorder.

FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME

Disclosed herein, in part, are fumagillol compounds and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.